In contrast, AD severity based on immunohistochemical features (Braak et al., 2006) was significantly linked to aggregate tau‐IP levels of 13 proteins (18%) after adjustment for age and PMI effects—substantially more frequently than expected by chance. Here, MAPT is linked to Alzheimer disease.